DUCTAL CARCINOMA IN SITU

This study is testing whether a shorter, 5-session radiation treatment is safe and effective for women with early-stage breast cancer. Researchers want to see if this condensed schedule controls cancer recurrence while causing acceptable side effects and maintaining good quality …

This study is testing if active monitoring and hormone therapy can be a safe and effective way to manage a very early form of breast cancer called DCIS, potentially avoiding surgery. It will enroll 400 women who will receive either standard or newer hormone therapies and be close…

This study is testing a special tattoo ink designed to fade over time. It aims to see if this 'Magic Ink' is as safe and effective as standard permanent tattoo ink for marking the skin to guide daily radiation therapy in women with breast cancer. Researchers will also check if th…

This study is testing a new way to mark the area where a breast tumor was removed during surgery. The goal is to help doctors more accurately target radiation therapy afterward and to better identify if any additional tissue needs to be removed. It involves 50 adults with early-s…

This study is testing whether adding a vaccine to standard hormone therapy can help prevent breast cancer in women with ductal carcinoma in situ (DCIS), which are abnormal cells that haven't spread. Women will receive either hormone therapy alone or hormone therapy plus a vaccine…

This study aims to understand if a person's life circumstances—like income, housing, and stress levels—are linked to inflammation in the body, which can affect breast cancer. Researchers will enroll 200 women with newly diagnosed breast cancer who haven't started treatment. Parti…